or Try an Advanced Search...

    Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 317.09 0.93% 2.92
    MDGL closed up 0.93 percent on Wednesday, November 20, 2024, on 77 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical MDGL trend table...
    Date Alert Name Type % Chg
    Golden Cross Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Wide Bands Range Expansion 0.93%
    Multiple of Ten Bullish Other 4.48%
    Wide Bands Range Expansion 4.48%
    MACD Bearish Signal Line Cross Bearish 9.88%
    20 DMA Support Bullish 9.88%
    Multiple of Ten Bearish Other 9.88%
    Wide Bands Range Expansion 9.88%
    Older End-of-Day Signals for MDGL ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    10 DMA Resistance about 21 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    Rose Above Previous Day's High about 21 hours ago
    Up 2% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MDGL Chart by TradingView
    Basic chart:

    Profile

    Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medication Lipid Metabolic Disease Endocrine System Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Hyperlipidemia Vascular And Metabolic Diseases

    Is MDGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra
    Nov 18 The first MASH drug could open the door for others — including GLP-1s
    Nov 15 Madrigal Pharmaceuticals gains amid takeover speculation
    Nov 15 John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC
    Nov 14 Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves
    Nov 11 Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
    Nov 10 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
    Nov 8 5 Small Drug Stocks to Buy as Trump Gets Re-Elected
    Nov 7 3 High Growth Tech Stocks Leading The US Market
    Nov 6 Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
    See more MDGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 368.29
    52 Week Low 168.2462
    Average Volume 427,098
    200-Day Moving Average 247.70
    50-Day Moving Average 248.39
    20-Day Moving Average 293.79
    10-Day Moving Average 322.54
    Average True Range 17.52
    RSI (14) 61.98
    ADX 37.11
    +DI 35.02
    -DI 23.83
    Chandelier Exit (Long, 3 ATRs) 315.73
    Chandelier Exit (Short, 3 ATRs) 253.19
    Upper Bollinger Bands 396.53
    Lower Bollinger Band 191.05
    Percent B (%b) 0.61
    BandWidth 69.94
    MACD Line 21.64
    MACD Signal Line 24.30
    MACD Histogram -2.6602
    Fundamentals Value
    Market Cap 6.26 Billion
    Num Shares 19.7 Million
    EPS -19.24
    Price-to-Earnings (P/E) Ratio -16.48
    Price-to-Sales 0.00
    Price-to-Book 168.57
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 336.82
    Resistance 3 (R3) 336.93 330.46 333.53
    Resistance 2 (R2) 330.46 325.43 330.41 332.44
    Resistance 1 (R1) 323.78 322.33 327.12 323.67 331.34
    Pivot Point 317.31 317.31 318.98 317.25 317.31
    Support 1 (S1) 310.62 312.28 313.96 310.51 302.84
    Support 2 (S2) 304.15 309.18 304.10 301.74
    Support 3 (S3) 297.47 304.15 300.65
    Support 4 (S4) 297.36